Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT‐AF

BACKGROUND: Oral anticoagulation (OAC) reduces stroke risk in atrial fibrillation, but bleeding is a frequent side effect. The decision to discontinue or modify medication regimens in response to a bleeding event may differ according to bleeding site and severity. METHODS AND RESULTS: We used data f...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Brien, Emily C., Holmes, DaJuanicia N., Thomas, Laine, Fonarow, Gregg C., Kowey, Peter R., Ansell, Jack E., Mahaffey, Kenneth W., Gersh, Bernard J., Peterson, Eric D., Piccini, Jonathan P., Hylek, Elaine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220555/
https://www.ncbi.nlm.nih.gov/pubmed/29886422
http://dx.doi.org/10.1161/JAHA.117.006391

Ejemplares similares

Ejemplares similares